Want to join the conversation?
$MRK 2Q15 Call: Last month, the FDA accepted the supplemental BLA for KEYTRUDA, an advanced non-small cell lung cancer, and granted KEYTRUDA Priority Review. This past week, the European Commission approved KEYTRUDA for the treatment of advanced melanoma in adults, both as a first line therapy and in previously treated patients.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!